Opdivo, also known as pembrolizumab, is a groundbreaking targeted therapy used in the fight against cancer. This innovative drug belongs to a class of medications called immune checkpoint inhibitors. Immune checkpoint inhibitors act on the body's own immune system, specifically by blocking proteins that prevent T cells from attacking malignant cell